Table 1 Baseline characteristics of subjects(n = 280)
Characteristic | Patients |
|---|---|
Age | 50.00 (44.00–58.00) |
BMI | 23.11 (21.50–25.57) |
Number SLNM | 1.00 (1.00–2.00) |
Histological stage | |
 Midddle/low | 231(82.50%) |
 High | 25(8.93%) |
 Unknown | 24(8.57%) |
Tumor size (cm) | Â |
  ≤ 2 | 93 (33.21%) |
  > 2 | 187 (66.79%) |
Ki-67 | |
 Negative | 203 (72.50%) |
 Positive | 75 (26.79%) |
 Unknown | 2 (0.71%) |
HER2 | Â |
 Negative | 215 (76.79%) |
 Positive | 63 (22.50%) |
 Unknown | 2 (0.71%) |
ER | |
 Negative | 47 (16.79%) |
 Positive | 233 (83.21%) |
PR | |
 Negative | 77 (27.50%) |
 Positive | 203 (72.50%) |
LVI | |
 Negative | 136 (48.57%) |
 Positive | 144 (51.43%) |
menopause | |
 No | 163 (58.21%) |
 Yes | 117 (41.79%) |